Balance Sheet Details

3 Months Ended

Mar. 31, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Balance Sheet Details

5. BALANCE SHEET DETAILS

Prepaid expenses and other current assets consisted of the following (in thousands):

	March 31, 2023		December 31, 2022
Prepaid clinical costs	$	1,892	$	2,567
Prepaid research and development costs		1,170		2,293
Australian tax incentive receivable		978		937
Prepaid insurance		583		939
Interest receivable		1,272		1,353
Due from Radionetics		99		135
Other		3,287		2,535
Total	$	9,281	$	10,759

Property and equipment, net consisted of the following (in thousands):

	March 31, 2023			December 31, 2022
Leasehold improvements	$	3,516		$	3,516
Lab equipment		3,212			3,168
Office equipment		859			859
Computers and software		46			41
Property and equipment at cost		7,633			7,584
Less accumulated depreciation and amortization		(4,367	)		(4,084	)
Total	$	3,266		$	3,500

Accounts payable and accrued expenses consisted of the following (in thousands):

	March 31, 2023		December 31, 2022
Accounts payable	$	5,895	$	6,883
Accrued clinical costs		2,918		1,921
Accrued research and development costs		3,580		4,043
Accrued outside services and professional fees		2,926		1,810
Other accrued expenses		977		694
Total	$	16,296	$	15,351